Pacific Edge reported NZD1.02B in Ordinary Share Capital for its fiscal semester ending in June of 2026.





Ordinary Share Capital Change Date
Pacific Edge NZD 1.02B 497K Jun/2026
Paradigm Biopharmaceuticals AUD 428.52M 39.09M Dec/2025
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025